Science

Can we stop antibiotic resistance from ruining promising drugs before they reach patients?

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 23/10/2026, 19:40:24 UTC.

Briefings

Researchers from Hungary propose a five-step framework to predict antibiotic resistance risks early in drug development, aiming to refine candidates and prevent costly failures. The study, published in Nature Reviews Microbiology, suggests this approach could stop resistance from ruining promising drugs before they reach patients. The framework integrates biological research centers and molecular medicine expertise to identify specific resistance risks during the early stages of drug development.

Key points

• Researchers from the HUN-REN Biological Research Centre in Szeged and the Hungarian Centre of Excellence for Molecular Medicine in Szeged propose a five-step decision-making framework.
• The framework aims to identify which antibiotics bacteria are most likely to become resistant to early in drug development.

Context

This review addresses the critical challenge of antibiotic resistance ruining promising drugs before they reach patients, offering a potential solution through a new decision-making framework.

Limitations

The evidence is limited to a review article published in Nature Reviews Microbiology. Specific details about the five-step framework, the exact biological mechanisms, or the specific numbers of resistant bacteria are not provided in the source text.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 23/10/2026, 19:54:50 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeifz2l6zbiqthrkvxxa7t23xf45gpfyngf2zg7bthqmer6taqiq2t4